Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer

NCT06775470 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DIAGNOSTIC_TEST: Patients must have been diagnosed with ovarian cancer and be BRCA positive
DIAGNOSTIC_TEST: BRCA1 and BRCA2 positive, and be affected by Ovarian Cancer

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna